$1.63 Billion is the total value of QVT Financial LP's 84 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 60.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | Buy | SPDR SERIES TRUSTput | $289,296,000 | -26.3% | 5,600,000 | +0.1% | 17.74% | -19.5% |
| GS | Buy | GOLDMAN SACHS GROUP INC | $79,174,000 | +485.7% | 504,356 | +572.5% | 4.86% | +539.7% |
| New | TAL ED GROUPnote 2.500% 5/1 | $46,707,000 | – | 24,000,000 | +100.0% | 2.86% | – | |
| MRVL | Buy | MARVELL TECHNOLOGY GROUP LTDord | $40,448,000 | +99.5% | 3,923,182 | +70.7% | 2.48% | +117.9% |
| QIHU | New | QIHOO 360 TECHNOLOGY CO LTDads | $40,121,000 | – | 531,047 | +100.0% | 2.46% | – |
| INTC | Buy | INTEL CORP | $39,473,000 | +168.0% | 1,220,176 | +185.4% | 2.42% | +192.7% |
| New | SHIP FINANCE INTERNATIONAL Lnote 3.250% 2/0 | $37,258,000 | – | 38,000,000 | +100.0% | 2.28% | – | |
| MMYT | Buy | MAKEMYTRIP LIMITED MAURITIUS | $35,041,000 | +38.3% | 2,034,024 | +31.3% | 2.15% | +51.0% |
| PFF | New | ISHARES TRput | $32,005,000 | – | 820,000 | +100.0% | 1.96% | – |
| Buy | CLOVIS ONCOLOGY INCnote 2.500% 9/1 | $29,665,000 | +34.1% | 43,295,000 | +69.8% | 1.82% | +46.5% | |
| NYT | Buy | NEW YORK TIMES COcl a | $29,006,000 | +2.9% | 2,327,896 | +10.8% | 1.78% | +12.4% |
| NAT | New | NORDIC AMERICAN TANKERS LIMIput | $26,947,000 | – | 1,912,500 | +100.0% | 1.65% | – |
| ATEX | Buy | PDVWIRELESS INC | $26,802,000 | +23.6% | 876,699 | +1.4% | 1.64% | +35.0% |
| NRE | Buy | NORTHSTAR REALTY EUROPE CORP | $26,689,000 | +37.0% | 2,300,786 | +39.5% | 1.64% | +49.6% |
| WFC | Buy | WELLS FARGO & CO NEW | $24,864,000 | +15.8% | 514,153 | +30.2% | 1.52% | +26.6% |
| THC | Buy | TENET HEALTHCARE CORP | $23,312,000 | -0.0% | 805,823 | +4.7% | 1.43% | +9.2% |
| KANG | New | IKANG HEALTHCARE GROUP INCsponsored adr | $21,111,000 | – | 965,717 | +100.0% | 1.30% | – |
| BLK | New | BLACKROCK INCput | $20,434,000 | – | 60,000 | +100.0% | 1.25% | – |
| XLRN | Buy | ACCELERON PHARMA INC | $18,537,000 | -40.6% | 702,410 | +9.7% | 1.14% | -35.1% |
| AGEN | Buy | AGENUS INC | $16,129,000 | +32.5% | 3,877,072 | +44.6% | 0.99% | +44.8% |
| NAT | New | NORDIC AMERICAN TANKERS LIMI | $15,937,000 | – | 1,131,120 | +100.0% | 0.98% | – |
| EPZM | Buy | EPIZYME INC | $14,317,000 | +50.1% | 1,181,244 | +98.4% | 0.88% | +64.1% |
| JPM | Buy | JPMORGAN CHASE & CO | $13,436,000 | +60.4% | 226,879 | +78.8% | 0.82% | +75.3% |
| New | QIMONDA FIN LLCnote 6.750% 3/2 | $12,872,000 | – | 82,885,000 | +100.0% | 0.79% | – | |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $11,955,000 | +50.6% | 558,625 | +122.4% | 0.73% | +64.3% |
| XLNX | New | XILINX INC | $11,234,000 | – | 236,855 | +100.0% | 0.69% | – |
| Z | Buy | ZILLOW GROUP INCcl c cap stk | $11,034,000 | +10.6% | 465,000 | +9.4% | 0.68% | +20.9% |
| ICPT | Buy | INTERCEPT PHARMACEUTICALS IN | $10,283,000 | +1519.4% | 80,044 | +1782.9% | 0.63% | +1652.8% |
| ARWR | Buy | ARROWHEAD RESH CORP | $9,870,000 | -17.8% | 2,047,782 | +4.9% | 0.60% | -10.2% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $8,767,000 | +215.4% | 106,289 | +300.5% | 0.54% | +244.9% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $8,775,000 | +83.7% | 449,526 | +263.0% | 0.54% | +100.7% |
| RY | New | ROYAL BK CDA MONTREAL QUEput | $8,634,000 | – | 150,000 | +100.0% | 0.53% | – |
| KKR | New | KKR & CO L P DEL | $8,287,000 | – | 564,149 | +100.0% | 0.51% | – |
| LBIO | Buy | LION BIOTECHNOLOGIES INC | $8,119,000 | -26.6% | 1,598,309 | +11.5% | 0.50% | -19.8% |
| HALO | Buy | HALOZYME THERAPEUTICS INC | $6,576,000 | -22.0% | 694,436 | +42.8% | 0.40% | -14.8% |
| ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $6,371,000 | -20.6% | 783,645 | +17.7% | 0.39% | -13.3% |
| AVXS | New | AVEXIS INC | $6,224,000 | – | 242,756 | +100.0% | 0.38% | – |
| ALR | New | ALERE INC | $5,083,000 | – | 100,442 | +100.0% | 0.31% | – |
| BGNE | New | BEIGENE LTDsponsored adr | $4,983,000 | – | 170,000 | +100.0% | 0.31% | – |
| BLCM | Buy | BELLICUM PHARMACEUTICALS INC | $4,749,000 | -31.3% | 507,939 | +49.0% | 0.29% | -25.0% |
| RGNX | Buy | REGENXBIO INC | $4,527,000 | -12.7% | 424,368 | +20.7% | 0.28% | -4.5% |
| Buy | ARRAY BIOPHARMA INCnote 3.000% 6/0 | $3,685,000 | +29.2% | 4,600,000 | +53.3% | 0.23% | +41.2% | |
| ASMB | Buy | ASSEMBLY BIOSCIENCES INC | $3,049,000 | -15.7% | 740,700 | +38.4% | 0.19% | -7.9% |
| MTG | New | MGIC INVT CORP WIS | $1,342,000 | – | 175,000 | +100.0% | 0.08% | – |
| OCN | New | OCWEN FINL CORP | $741,000 | – | 300,000 | +100.0% | 0.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MAKEMYTRIP LIMITED MAURITIUS | 38 | Q3 2023 | 6.2% |
| NEW YORK TIMES CO | 34 | Q3 2023 | 2.6% |
| ACCELERON PHARMA INC | 32 | Q3 2021 | 2.8% |
| JPMORGAN CHASE & CO | 32 | Q3 2021 | 2.2% |
| SAREPTA THERAPEUTICS INC | 32 | Q3 2023 | 1.1% |
| BIOMARIN PHARMACEUTICAL INC | 32 | Q3 2023 | 0.5% |
| GOLDMAN SACHS GROUP INC | 30 | Q3 2023 | 5.4% |
| ACADIA PHARMACEUTICALS INC | 28 | Q3 2023 | 0.2% |
| WELLS FARGO CO NEW | 27 | Q4 2020 | 1.5% |
| NEXSTAR MEDIA GROUP INC | 26 | Q3 2023 | 3.4% |
View QVT Financial LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| MP Materials Corp. / DE | May 18, 2023 | 8,853,712 | 5.0% |
| Grindrod Shipping Holdings Ltd.Sold out | February 14, 2022 | 0 | 0.0% |
| AEHR TEST SYSTEMSSold out | February 14, 2020 | 0 | 0.0% |
| Arbutus Biopharma CorpSold out | July 12, 2019 | 0 | 0.0% |
| Axovant Gene Therapies Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Myovant Sciences Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Urovant Sciences Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Axovant Sciences Ltd. | March 19, 2019 | 105,952,381 | 58.2% |
| Hunter Maritime Acquisition Corp.Sold out | February 14, 2019 | 0 | 0.0% |
| AGENUS INC | February 14, 2018 | 3,201,263 | 3.2% |
View QVT Financial LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 4 | 2024-03-07 |
| SC 13G/A | 2024-03-07 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-02 |
| 144 | 2023-09-28 |
| 13F-HR | 2023-08-14 |
| SC 13D/A | 2023-05-18 |
View QVT Financial LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.